Cargando…

High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma

BACKGROUND: High-dose chemotherapy with autologous stem cell transplantation is a cornerstone in the first-line treatment of multiple myeloma patients. However, only few factors have been identified affecting the outcome in such patients. We hypothesised that varying levels of mobilised CD34+ cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raschle, J, Ratschiller, D, Mans, S, Mueller, B U, Pabst, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185945/ https://www.ncbi.nlm.nih.gov/pubmed/21878938 http://dx.doi.org/10.1038/bjc.2011.329

Ejemplares similares

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Plerixafor for autologous CD34(+) cell mobilization
por: Salman, Huda, et al.
Publicado: (2011)

Circulating CD3(+)CD4(+)CD161(+) Cells Are Associated with Early Complications after Autologous Stem Cell Transplantation in Multiple Myeloma
por: Lee, Sung-Eun, et al.
Publicado: (2018)

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma
por: Biran, Noa, et al.
Publicado: (2021)

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020)

Therapeutic Angiogenesis Using Autologous CD34-Positive Cells for Vascular Diseases
por: Fujita, Yasuyuki, et al.
Publicado: (2022)

Autologous Transplantation for Older Adults with AML
por: Mueller, Beatrice U., et al.
Publicado: (2018)

Differential Expression of MicroRNAs in CD34+ Cells of 5q- Syndrome
por: Votavova, Hana, et al.
Publicado: (2011)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020)

Increased circulating CD4(+)FOXP3(+) T cells associate with early relapse following autologous hematopoietic stem cell transplantation in multiple myeloma patients
por: Batorov, Egor V., et al.
Publicado: (2018)

Generation and Characterization of Anti-CD34 Monoclonal Antibodies that React with Hematopoietic Stem Cells
por: Aghebati Maleki, Leili, et al.
Publicado: (2014)

Impairment in the telocyte/CD34(+) stromal cell network in human rheumatoid arthritis synovium
por: Rosa, Irene, et al.
Publicado: (2020)

Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
por: Xu, Jingyu, et al.
Publicado: (2023)

Mobilization and collection of CD34(+) cells for autologous transplantation of peripheral blood hematopoietic progenitor cells in children: analysis of two different granulocyte-colony stimulating factor doses
por: Eid, Kátia Aparecida de Brito, et al.
Publicado: (2015)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

Autologous Adipocyte Derived Stem Cells Favour Healing in a Minipig Model of Cutaneous Radiation Syndrome
por: Forcheron, Fabien, et al.
Publicado: (2012)

Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
por: Wang, Tongguang, et al.
Publicado: (2013)

Circulating hematopoietic progenitors and CD34(+) cells predicted successful hematopoietic stem cell harvest in myeloma and lymphoma patients: experiences from a single institution
por: Yu, Jui-Ting, et al.
Publicado: (2016)

FISH(+)CD34(+)CD38(-) cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
por: Wang, Libing, et al.
Publicado: (2013)

Intramyocardial transplantation of circulating CD34+ cells: source of stem cells for myocardial regeneration.
por: Kim, Yong-Hwan
Publicado: (2003)

Long term immune reconstitution after immunoablation and autologous CD34 cell therapy in autoimmune diseases
por: Thiel, AT, et al.
Publicado: (2002)

Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair
por: Kuroda, Ryosuke, et al.
Publicado: (2023)

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era
por: Chakraborty, R, et al.
Publicado: (2016)

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2019)

Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women - a pilot study
por: Ludwig, Antje, et al.
Publicado: (2010)

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia
por: Haas, Matthias, et al.
Publicado: (2009)

Cardiac telocytes are double positive for CD34/PDGFR-α
por: Zhou, Qiulian, et al.
Publicado: (2015)

Successful autologous stem cell collection with filgrastim and plerixafor after long-term lenalidomide therapy for multiple myeloma
por: Agarwal, Rishi, et al.
Publicado: (2012)

Correction: Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
Publicado: (2014)

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
por: Heini, Alexander D., et al.
Publicado: (2021)

Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients
por: Lau, K-M, et al.
Publicado: (2007)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
por: Minnie, Simone A., et al.
Publicado: (2021)

Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study
por: Wang, Liming, et al.
Publicado: (2013)

Effect of Weight Reduction on Cardiovascular Risk Factors and CD34-positive Cells in Circulation
por: Mikirova, Nina A, et al.
Publicado: (2011)

P1018: TREND OF CIRCULATING CD34+ CELLS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
por: Cattaneo, D., et al.
Publicado: (2022)

Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis
por: Gardellini, A, et al.
Publicado: (2013)

Coronary circulating mononuclear progenitor cells and soluble biomarkers in the cardiovascular prognosis after coronary angioplasty
por: Suárez‐Cuenca, Juan Antonio, et al.
Publicado: (2019)

Study of Peripheral Mononuclear Cells and CD34 Levels as a Predictive Marker for Initiating Apheresis in Autologous Stem Cell Transplant
por: Pura Krishnamurthy, Kiran, et al.
Publicado: (2021)

Influence of hemodialysis on circulating CD4(low)CD25(high) regulatory T cells in end-stage renal disease patients
por: Lisowska, Katarzyna A., et al.
Publicado: (2013)

Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34(+ )cells
por: Deola, Sara, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ahf9rfpkqfg12i62dmc574fojc